Year-over-year net earnings per share growth for the last 12 months: Codexis, Inc. (CDXS)
Codexis, Inc. (CDXS) is recognized as a global authority in biocatalysis, enjoying the absolute trust of the largest pharmaceutical behemoths. This GURU.Markets chart illustrates the current quarterly EPS growth rate, where 15.00 reflects the metric's baseline. Growth potential is based on new licenses in the field of RNA therapeutics, while the company's environmental solutions to reduce energy costs and toxic emissions ensure compliance with ESG standards.
Analytical breakdowns and data insights for company Codexis, Inc. (CDXS)
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- book capitalization indicators:
- business debt structure and liquidity details:
Total Debt to Capital Codexis, Inc.|CDXS - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio codexis.com|CDXS - Company Total Debt Obligations|Debts to Book Capitalization Codexis Bio|CDXS - Company Long-Term Liabilities|Company Short-Term Debts Codexis, Inc.|Quick Liquidity Indicator codexis.com
- earnings and valuation multiples indicators:
CDXS - Company Profit|Expected Profit Codexis, Inc.|CDXS - Business Payback Period|Forward P/E Multiple codexis.com|CDXS - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Codexis Bio|CDXS - Operating profit before amortization|Net earnings per share (EPS TTM) Codexis, Inc.|CDXS - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth codexis.com|CDXS - Net earnings per share growth this year|Net earnings per share growth forecast for next year Codexis, Inc.
Analysis of all company metrics:Codexis Inc - CDXS
The performance of Codexis, Inc. (CDXS) is assessed through the quarterly growth of net earnings per share. This metric measures the speed at which operational efficiency is transformed into actual shareholder returns. By analyzing the quarterly EPS growth vector, investors track the pace of profit scaling relative to previous periods. For the business, this reflects the monetization of the CodeEvolver platform by reducing partner costs. A stable trend confirms the uniqueness of the technological ecosystem and the resilience of the capital.
Main competitors
Tempus AI Inc (TEM) - Year-over-year earnings per share growth for the last twelve months|QGEN - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months IONS|RGEN: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth RNA|Year-over-year net earnings per share change for the last twelve months crisprtx.com|Year-over-year earnings per share growth for the last twelve months GeneDx WGS|RARE: Year-over-year earnings per share growth for the last 12 months|Beam Therapeutics Corp - Quarterly EPS earnings growth|Sarepta Corp (SRPT) - Year-over-year net earnings per share growth for the last 12 months|TWST (Twist Bioscience) - Year-over-year net earnings per share growth for the last 12 months|TXG - Year-over-year net earnings per share change for the last twelve months|NTLA (Intellia Therapeutics, Inc.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Stoke Therapeutics Inc (STOK)|Quarterly EPS earnings growth BLFS|Wave Pharma - Year-over-year earnings per share growth for the last 12 months|Maze Therapeutics Inc - Year-over-year net earnings per share growth for the last 12 months|SION: Year-over-year earnings per share growth for the last 12 months|PRME - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Taysha Gene Therapies Inc TSHA|QURE: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months MGTX|Year-over-year earnings per share growth for the last twelve months REGENXBIO Inc.|Year-over-year earnings per share growth for the last 12 months SLDB (solidbio.com)|Quarterly EPS earnings growth OCGN|Quarterly EPS earnings growth Pacific Biosciences of California, Inc. (PACB)|Quarterly EPS earnings growth BNTC (Benitec)|DSGN - Year-over-year net earnings per share growth for the last 12 months|RCKT - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months 4dmoleculartherapeutics.com|LXEO: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months KRRO|EDIT (Editas) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Silence Therapeutics Corp SLN|Year-over-year net earnings per share growth for the last 12 months PRQR (ProQR Therapeutics N.V.)|sangamo.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth NAUT (Nautilus Bio)|Year-over-year net earnings per share change for the last twelve months Metagenomi Inc. (MGX)|DTIL - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Generation Bio Co. GBIO|BOLD (Boundless Bio, Inc.) - Year-over-year net earnings per share growth for the last 12 months|Exicure - Year-over-year earnings per one share growth for the last 12 months|IMNN (Imunon Inc) - Quarterly EPS earnings growth|RXi Pharmaceuticals (PHIO) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mustang Bio, Inc. (MBIO)|transcodetherapeutics.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth BNGO (Bionano Genomics)|APDN - Year-over-year net earnings per share growth for the last 12 months|BLUE: Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months ImmunoPrecise Antibodies IPA|OMGA: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Singular Genomics Corp|RGLS (Regulus Therapeutics) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months SYRS (syros.com)|Year-over-year net earnings per share growth for the last 12 months TBIO (Telesis Bio)|TRACON Pharmaceuticals Inc. - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Unity Bio UBX
